MALE GENDER IS ASSOCIATED WITH AN IMPAIRED OVERALL AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH PROGNOSTIC LOW RISK CHRONIC LYMPHOCYTIC LEUKEMIA

被引:0
|
作者
Da Cunha-Bang, C. [1 ]
Geisler, C. [2 ]
Enggaard, L. [3 ]
Poulsen, C. [4 ]
Brown, P. [2 ]
Frederiksen, H. [5 ]
Bergmann, O. [6 ]
Pulczynski, E. [7 ]
Pedersen, R. Schou [8 ]
Nielsen, L. [9 ]
Christiansen, I. [10 ]
Niemann, C.
机构
[1] Roskilde Hosp, Cardiol, Roskilde, Denmark
[2] Rigshosp, Hematol, Copenhagen, Denmark
[3] Herlev Hosp, Hematol, Herlev, Denmark
[4] Roskilde Hosp, Hematol, Roskilde, Denmark
[5] Odense Hosp, Hematol, Odense, Denmark
[6] Vejle Hosp, Hematol, Vejle, Denmark
[7] Aarhus Hosp, Hematol, Aarhus, Denmark
[8] Holstebro Hosp, Hematol, Holstebro, Denmark
[9] Esbjerg Cent Hosp, Hematol, Esbjerg, Denmark
[10] Aalborg Hosp, Hematol, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E1081
引用
收藏
页码:445 / 445
页数:1
相关论文
共 50 条
  • [1] LOW PLATELETCRIT IS ASSOCIATED WITH REDUCED PROGRESSION-FREE AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Ozbalci, Demircan
    Alanoglu, Emine Guchan
    Findos, Eda
    Eroglu, Hande Nur
    [J]. JOURNAL OF MEDICAL BIOCHEMISTRY, 2023, 42 (02) : 274 - 281
  • [2] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
  • [3] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M.
    Aissa, F.
    Lachaine, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
  • [4] Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
    Wierda, William G.
    O'Brien, Susan
    Wang, Xuemei
    Faderl, Stefan
    Ferrajoli, Alessandra
    Do, Kim-Anh
    Cortes, Jorge
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Koller, Charles
    Beran, Miloslav
    Giles, Francis
    Ravandi, Farhad
    Lerner, Susan
    Kantarjian, Hagop
    Keating, Michael
    [J]. BLOOD, 2007, 109 (11) : 4679 - 4685
  • [5] The prognostic impact of serum antinuclear antibodies on overall survival in patients with chronic lymphocytic leukemia
    Sun, Qian
    Wang, Li
    Zhu, Hua-Yuan
    Wu, Wei
    Liang, Jin-Hua
    Cao, Lei
    Xia, Yi
    Wu, Jia-Zhu
    Wang, Yan
    Wang, Rong
    Fan, Lei
    Xu, Wei
    Li, Jian-Yong
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 28 - 30
  • [6] Relationship between progression-free survival and overall survival in chronic lymphocytic leukemia: a literature-based analysis
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    [J]. CURRENT ONCOLOGY, 2015, 22 (03) : E148 - E156
  • [7] A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients
    Gentile, Massimo
    Shanafelt, Tait D.
    Cutrona, Giovanna
    Molica, Stefano
    Tripepi, Giovanni
    Alvarez, Isabel
    Romana Mauro, Francesca
    Di Renzo, Nicola
    Di Raimondo, Francesco
    Vincelli, Iolanda D.
    Todoerti, Katia
    Matis, Serena
    Musolino, Caterina
    Fabris, Sonia
    Vigna, Ernesto
    Levato, Luciano
    Zupo, Simona
    Angrilli, Francesco
    Consoli, Ugo
    Festini, Gianluca
    Longo, Giuseppe
    Cortelezzi, Agostino
    Arcari, Annalisa
    Federico, Massimo
    Mannina, Donato
    Grazia Recchia, Anna
    Kay, Neil E.
    Ferrarini, Manlio
    Neri, Antonino
    Morabito, Fortunato
    [J]. BLOOD, 2015, 126 (23)
  • [8] Response, Progression-Free Survival, and Overall Survival of patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Flavopiridol: Impact of Poor Risk Cytogenetic Abnormalities
    Woyach, Jennifer A.
    Ruppert, Amy S.
    Blum, Kristie A.
    Jones, Jeffrey Alan
    Flynn, Joseph M.
    Johnson, Amy J.
    Grever, Michael R.
    Byrd, John C.
    Heerema, Nyla A.
    [J]. BLOOD, 2010, 116 (21) : 1019 - 1020
  • [9] A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression
    Condoluci, Adalgisa
    di Bergamo, Lodovico Terzi
    De Paoli, Lorenzo
    Delgado, Julio
    Gentile, Massimo
    Doubek, Michael
    Mauro, Francesca Romana
    Mattsson, Mattias
    Cutrona, Giovanna
    Kotaskova, Jana
    Deambrogi, Clara
    Gerber, Bernhard
    Spina, Valeria
    Bruscaggin, Alessio
    Zucca, Emanuele
    Cavalli, Franco
    Stuessi, Georg
    Neri, Antonino
    Ferrarini, Manlio
    Rosenquist, Richard
    Foa, Robin
    Pospisilova, Sarka
    Morabito, Fortunato
    Montserrat, Emili
    Gaidano, Gianluca
    Wierda, William G.
    Rossi, Davide
    [J]. BLOOD, 2018, 132
  • [10] Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients
    Van Damme, Michael
    Crompot, Emerence
    Meuleman, Nathalie
    Mineur, Philippe
    Dessars, Barbara
    El Housni, Hakim
    Bron, Dominique
    Lagneaux, Laurence
    Stamatopoulos, Basile
    [J]. EPIGENETICS, 2014, 9 (10) : 1374 - 1381